Clinical Trial Update: A Study of PEG-somatropin in the Treatment of Children With Idiopathic Short Stature [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating PEG-somatropin for treating children with idiopathic short stature.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Short Stature

Drugs mentioned

• PEG-somatropin (pegylated somatropin)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Dwarfism | Phase 2 | Status: UNKNOWN